AI assistant
Sending…
IMMUCELL CORP /DE/ — Director's Dealing 2017
Feb 14, 2017
34519_dirs_2017-02-14_5817b1a6-46c9-46d6-9000-bd286cdaacd6.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: IMMUCELL CORP /DE/ (ICCC)
CIK: 0000811641
Period of Report: 2017-02-10
Reporting Person: BRIGHAM MICHAEL F (N/A)
Derivative Transactions
| Date | Security | Exercise Price | Code | Shares | A/D | Expiration | Underlying | Ownership |
|---|---|---|---|---|---|---|---|---|
| 2017-02-10 | Incentive stock options (right to buy) | $5.8400 | A | 25000.0000 | Acquired | 2027-02-09 | Common Stock (25000.0000) | Direct |
More from IMMUCELL CORP /DE/
Regulatory Filings
2026
May 14
Annual Report
2026
May 13
Regulatory Filings
2026
May 8
Proxy Solicitation & Information Statement
2026
Apr 24
Regulatory Filings
2026
Apr 14
Regulatory Filings
2026
Apr 14
Regulatory Filings
2026
Apr 8
Annual Report
2026
Mar 30
Director's Dealing
2026
Mar 25
Director's Dealing
2026
Mar 23